SCHEMBL11160646

SCHEMBL11160646

COc1cc2c(c(Sc3ccccc3)c1OC)CCN(C(=O)C1CC1)CC2

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 2/20 0.47
▸ KMT2A Q03164 5/20 0.44
▸ MEN1 O00255 4/20 0.44
▸ MTNR1B P49286 3/20 0.41
▸ USP2 O75604 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.40
▸ HPGD P15428 2/20 0.40
▸ MAPT P10636 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ PDE4B Q07343 1/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ THRB P10828 1/20 0.40
▸ PTGDR2 Q9Y5Y4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11167197 0.84 ALDH1A1 (0.45) GAAKMT2AMEN1TSHRKDM4E
SCHEMBL11160967 0.82 DRD1 (0.47) —
Fumaric Acid SCHEMBL11169294 0.81 MEN1 (0.43) GAAKMT2AMEN1KDM4EALDH1A1
Fumaric Acid SCHEMBL11169280 0.81 MEN1 (0.43) GAAKMT2AMEN1KDM4EALDH1A1
SCHEMBL11215748 0.79 CYP2D6 (0.41) KMT2AMEN1
SCHEMBL11171000 0.78 DRD1 (0.38) GAAKMT2AMEN1MTNR1BTSHR
SCHEMBL11169221 0.78 MEN1 (0.39) KMT2AMEN1
SCHEMBL11214362 0.76 LMNA (0.40) KMT2AMEN1MTNR1BUSP2KDM4E
SCHEMBL11162258 0.76 HTR6 (0.44) KMT2AMEN1
SCHEMBL11214359 0.75 KCNH2 (0.46) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0080012-A1 6-Chloro-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, its acid addition salts and its use as an intermediate SMITHKLINE BECKMAN CORPORATION (US) 1983-06-01 — — EP disclosed
EP-0007070-B1 2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINES, PROCESS FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS HAVING DOPAMINE RECEPTOR BLOCKING ACTIVITY SMITHKLINE BECKMAN CORPORATION (US) 1983-01-19 — — EP disclosed
US-4265890-A ANTIPSYCHOTIC, ANTIEMETICS SMITHKLINE CORPORATION (US) 1981-05-05 — — US disclosed
EP-0007070-A1 2,3,4,5-Tetrahydro-1H-3-Benzazepines, process for their production and pharmaceutical compositions having dopamine receptor blocking activity SMITHKLINE BECKMAN CORPORATION (US) 1980-01-23 — — EP disclosed
Send feedback